W. Grimminger

Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A

Richard F. Schlenk, Konstanze Döhner, Silja Mack et al. · Journal of Clinical Oncology · 2010 · 230 citations · Full text

Medicine, Hematology, Cell Therapy +13

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Richard F Schlenk, Stefan Fröhling, Frank Hartmann et al. · Leukemia · 2004 · 170 citations

Medicine, Hematology, Oncology +5

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Donald Bunjes, Inga Buchmann, Christian Duncker et al. · Blood · 2001 · 169 citations · Full text

Medicine, Hematology, Oncology +17

Randomized phase III study of granulocyte transfusions in neutropenic patients

Markus G. Seidel, Christina Peters, A. Wacker et al. · Bone Marrow Transplantation · 2008 · 150 citations

Medicine, Hematology, Transfusion Medicine +13

Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial

Richard F. Schlenk, Axel Benner, Frank Hartmann et al. · Leukemia · 2003 · 121 citations

Medicine, Hematology, Oncology +12